SD 254
Alternative Names: Deuterated venlafaxine; SD-254; Venlafaxine deuterium-substitutedLatest Information Update: 15 Jan 2015
Price :
$50 *
At a glance
- Originator Auspex Pharmaceuticals
- Class Antidepressants; Cyclohexanols; Dimethylamines; Organic deuterium compounds; Small molecules
- Mechanism of Action Adrenergic receptor antagonists; Serotonin uptake inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Major depressive disorder
- Discontinued Neuropathic pain
Most Recent Events
- 15 Jan 2015 Discontinued - Phase-I for Neuropathic pain in USA (PO)
- 15 Jul 2013 Phase-I clinical trials in Neuropathic pain in USA (PO)
- 24 Oct 2010 No development reported - Phase-I for Major depressive disorder in USA (PO)